Employing SIRT3 KO in a murine model of metabolic syndrome revealed that greater than 90% of SIRT3 KO mice developed HCC, providing an association with SIRT3 activity, metabolic syndrome, mitochondrial protein acetylation, and cancer progression [182]. This evidence concerns the gene SIRT3 and metabolic syndrome.